Please use this identifier to cite or link to this item:
|Title:||Oxygen therapy for COPD.||Austin Authors:||McDonald, Christine F||Affiliation:||Department of Respiratory and Sleep Medicine, Austin Health, Heidelberg, Victoria, Australia ; 2 Institute for Breathing and Sleep, Melbourne, Victoria, Australia ; 3 University of Melbourne, Melbourne, Victoria, Australia||Issue Date:||1-Nov-2014||Publication information:||Journal of Thoracic Disease; 6(11): 1632-9||Abstract:||Chronic obstructive pulmonary disease (COPD) is a leading cause of disability and death globally, characterised by progressive breathlessness, loss of function and, in its later stages, chronic hypoxaemia. Long-term continuous oxygen therapy increases life expectancy in patients with severe resting hypoxaemia. However, there are few data to support the use of oxygen in patients with only mild hypoxaemia and more research is required to determine any benefits of oxygen supplementation in COPD in such individuals.||Gov't Doc #:||25478203||URI:||http://ahro.austin.org.au/austinjspui/handle/1/12527||DOI:||10.3978/j.issn.2072-1439.2014.10.23||URL:||https://pubmed.ncbi.nlm.nih.gov/25478203||Type:||Journal Article||Subjects:||Oxygen
chronic obstructive pulmonary disease (COPD)
|Appears in Collections:||Journal articles|
Show full item record
checked on Nov 25, 2022
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.